A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers

Status:
Recruiting

Trial end date:
2024-10-07

Target enrollment:

Participant gender:

To understand if AGA2115 is safe and well tolerated in healthy adult volunteers.

Phase 1

Angitia Incorporated Limited